Research & Clinical Trials

The BTTC has experienced unparalleled advancements in the research of alternative treatments of malignant brain tumors. Subsequently research studies, also known as clinical trials, are being conducted to learn of promising advances to cancer prevention, diagnosis and treatments that are safe and effective. The BTTC is now concluding the initial steps of its cutting-edge clinical trials involving malignant glioma tumors. Next step: introduce the trials to the community.

BTTC Research

Malignant glioma brain tumor have the greatest incidence rate in adults, while the survival rate remains poor. Pre-clinical data suggests alternative therapy strategies, including a multi-targeted approach, might be more effective in controlling the tumor and subsequently improving survival.

Learn more about BTTC Research

Clinical Trial Basics

Within the world of cancer research, four types of clinical trials exist — prevention, diagnosis, screening and quality of life.

Learn more about the Clinical Trial Basics

Open BTTC Clinical Trials

The current treatment of malignant gliomas, the most common brain tumor in adults, remains challenging and less effective than desired. Several trials are in the planning stages, but two current BTTC clinical trials are available for patients. Those trials hope to deliver results that provide a more effective treatment therapy in controlling the tumor and, ultimately, increase survival.

Learn more about the Open Clinical Trials